UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Nature genetics, ISSN 1061-4036, 10/2009, Volume 41, Issue 10, pp. 1100 - 1104
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Fundamental and applied biological sciences. Psychology | Viral hepatitis | Infectious diseases | Viral diseases | Biological and medical sciences | Genetics of eukaryotes. Biological and molecular evolution | Medical sciences | Human viral diseases | Genome-Wide Association Study | Antiviral Agents - therapeutic use | Humans | Middle Aged | Ribavirin - therapeutic use | Gene Expression Regulation | Interferon-alpha - therapeutic use | Hepatitis C, Chronic - virology | Genotype | Male | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Polyethylene Glycols - therapeutic use | Interleukins - genetics | Adult | Female | Polymorphism, Single Nucleotide | Australia | Drug Therapy, Combination | Hepatitis C, Chronic - genetics | Index Medicus
Journal Article
World journal of gastroenterology : WJG, ISSN 1007-9327, 08/2015, Volume 21, Issue 29, pp. 8848 - 8857
Sustained virologic response? | Rs8099917 | Rs12979860 | Chronic hepatitis C | Pegylated interferon | Recombinant Proteins - therapeutic use | Multivariate Analysis | Prospective Studies | Humans | Middle Aged | Hepacivirus - genetics | Male | RNA, Viral - blood | Polyethylene Glycols - therapeutic use | Viral Load | Interleukins - genetics | Iran | Adult | Female | Drug Therapy, Combination | Odds Ratio | Hepacivirus - drug effects | Pharmacogenetics | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Genotype | Logistic Models | Treatment Outcome | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Phenotype | Hepatitis C, Chronic - immunology | Polymorphism, Single Nucleotide | Hepatitis C, Chronic - genetics | Index Medicus | Prospective Study | rs12979860 | rs8099917 | Sustained virologic response
Journal Article
Liver international, ISSN 1478-3223, 02/2014, Volume 34, Issue 1, pp. 69 - 78
sofosbuvir | faldaprevir | ribavirin | simeprevir | pegylated interferon | asunaprevir | daclatasvir | Daclatasvir | Simeprevir | Pegylated interferon | Faldaprevir | Asunaprevir | Ribavirin | Sofosbuvir | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Heterocyclic Compounds, 3-Ring | Hepatitis C - drug therapy | Oligopeptides | Isoquinolines | Humans | Hepacivirus - genetics | Drug Discovery - methods | Disease Eradication - methods | Recombinant Proteins | Protease Inhibitors - pharmacology | Thiazoles | Hepacivirus - drug effects | Virus Replication - drug effects | Antiviral Agents - pharmacology | Polyethylene Glycols | Antiviral Agents - therapeutic use | Interferon-alpha | Clinical Trials as Topic | Disease Eradication - trends | Drug Therapy, Combination - methods | Drug Therapy, Combination - trends | Imidazoles | Sulfonamides | Uridine Monophosphate - analogs & derivatives | Viral Nonstructural Proteins - antagonists & inhibitors | Virus Replication - physiology | Hepatitis C virus | Biological response modifiers | Interferon | Index Medicus
Journal Article
Journal of viral hepatitis, ISSN 1352-0504, 10/2012, Volume 19, Issue 10, pp. 694 - 703
anti‐interferon‐α neutralizing antibody | nonresponse | natural interferon‐β | chronic hepatitis C | pegylated interferon‐α | pegylated interferon-α | anti-interferon-α neutralizing antibody | natural interferon-β | Humans | Middle Aged | Male | Neutralization Tests | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Interferon-alpha - immunology | Interferon-alpha - administration & dosage | Ribavirin - administration & dosage | Adult | Female | Aged | Antibodies, Neutralizing - blood | Index Medicus
Journal Article
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], ISSN 1424-3903, 10/2018, Volume 18, Issue 7, pp. 691 - 699
Journal Article
The Pediatric infectious disease journal, ISSN 0891-3668, 12/2020, Volume 39, Issue 12, pp. 1121 - 1126
chronic hepatitis B | meta-analysis | pegylated interferon | children | Pediatrics | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Medical colleges | Medical research | Analysis | Medicine, Experimental | Development and progression | Interferon | Biological response modifiers | Drug therapy | Hepatitis B | Index Medicus
Journal Article
Leukemia research, ISSN 0145-2126, 2017, Volume 54, pp. 73 - 77
Hematology, Oncology and Palliative Medicine | Polycythemia vera | Myelofibrosis | Pegylated interferon | Myeloproliferative neoplasms | Essential thrombocytosis | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Recombinant Proteins - therapeutic use | Thrombocythemia, Essential - drug therapy | Primary Myelofibrosis - drug therapy | Humans | Middle Aged | Interferon-alpha - therapeutic use | Polyethylene Glycols - adverse effects | Male | Treatment Outcome | Fatigue - chemically induced | Myeloproliferative Disorders - drug therapy | Recombinant Proteins - adverse effects | Polyethylene Glycols - therapeutic use | Leukopenia - chemically induced | Adult | Polycythemia Vera - drug therapy | Aged | Bone Marrow Neoplasms - drug therapy | Interferon-alpha - adverse effects | Myeloproliferative Disorders - complications | Retrospective Studies | Clinical trials | Biological response modifiers | Interferon alpha | Tumors | Medical colleges | Index Medicus
Journal Article
Journal of immunotherapy (1997), ISSN 1524-9557, 10/2010, Volume 33, Issue 8, pp. 834 - 839
pegylated interferon | drug reaction | response | Morbus Boeck | granuloma | Oncology | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Tumors of the skin and soft tissue. Premalignant lesions | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Dermatology | Immunotherapy | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antineoplastic agents | Melanoma - epidemiology | Granuloma | Melanoma - complications | Sarcoidosis - diagnosis | Diagnosis, Differential | Melanoma - diagnosis | Humans | Middle Aged | Male | Sarcoidosis - etiology | Withholding Treatment | Disease Progression | Incidence | Interferon-alpha - administration & dosage | Sarcoidosis - epidemiology | Neoplasm Metastasis | Hepatitis C - epidemiology | Melanoma - drug therapy | Sarcoidosis - physiopathology | Interferon-alpha - adverse effects | Retrospective Studies | Melanoma - physiopathology | Index Medicus
Journal Article
Journal of gastroenterology and hepatology, ISSN 0815-9319, 06/2015, Volume 30, Issue 6, pp. 1075 - 1084
peripheral blood mononuclear cells | hepatitis C virus | pegylated interferon | type III interferon | NS3 protease inhibitor | Peripheral blood mononuclear cells | Type III interferon | Hepatitis C virus | Pegylated interferon | Gene Expression - genetics | Humans | Middle Aged | Interferon-alpha - therapeutic use | Male | Hepatitis C, Chronic - drug therapy | Drug Resistance - genetics | Interleukins - genetics | Interleukins - physiology | Alleles | Adult | Female | Aged | Polymorphism, Single Nucleotide | Interleukins - biosynthesis | Hepatitis C, Chronic - genetics | RNA, Messenger | Index Medicus
Journal Article
Journal of cellular biochemistry, ISSN 0730-2312, 05/2019, Volume 120, Issue 5, pp. 8154 - 8159
rs12979860 | IL28β gene polymorphism | PEGylated interferon/ribavirin | sustained virological response | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Therapy | Viruses | Gene polymorphism | Patients | Ribavirin | Polymerase chain reaction | Hepatitis | Genotype & phenotype | Interferon | Genetic factors | Hepatitis C virus | Hepatitis C | Genotypes | Polymorphism
Journal Article
11.
Full Text
Interaction of PEGylated interferon-beta with antibodies to recombinant interferon-beta
International immunopharmacology, ISSN 1567-5769, 09/2018, Volume 62, pp. 1 - 6
NABs | Multiple sclerosis | Plegridy | Interferonβ | PEGylated IFNβ | Neutralizing antibodies | Pharmacology & Pharmacy | Immunology | Life Sciences & Biomedicine | Science & Technology | A549 Cells | Interferon-beta - immunology | Multiple Sclerosis - blood | Polyethylene Glycols | Humans | Cytopathogenic Effect, Viral | Neutralization Tests | Encephalomyocarditis virus - immunology | Cross Reactions | Recombinant Proteins - immunology | Multiple Sclerosis - immunology | Biological Assay | Antibodies, Neutralizing - blood | Myxovirus Resistance Proteins - biosynthesis | Viral antibodies | Medical research | Medical colleges | Analysis | Interferon beta | Medicine, Experimental | Antibodies | Biological response modifiers | Formulations | Antigens | Immunoglobulins | Myxovirus resistance proteins | β-Interferon | Bias | Cross-reactivity | Assaying | Patients | Biological activity | Proteins | Interferon | In vivo methods and tests | Physicochemical properties | Index Medicus
Journal Article